Healthcare provider profile · identity verified

Stephen A Roy, MD

Internal Medicine · HUNTINGTON, WV · NPI 1194160010

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	249	74
Losartan Potassium	Losartan Potassium	195	62
Amlodipine Besylate	Amlodipine Besylate	183	59
Levothyroxine Sodium	Levothyroxine Sodium	146	43
Omeprazole	Omeprazole	141	43
Lisinopril	Lisinopril	137	43
Metoprolol Succinate	Metoprolol Succinate	134	39
Metformin Hcl	Metformin Hcl	126	36
Jardiance	Empagliflozin	107	24
Rosuvastatin Calcium	Rosuvastatin Calcium	105	32
Hydrochlorothiazide	Hydrochlorothiazide	102	36
Pantoprazole Sodium	Pantoprazole Sodium	102	30
Gabapentin	Gabapentin	95	27
Clopidogrel	Clopidogrel Bisulfate	89	23
Tamsulosin Hcl	Tamsulosin Hcl	88	30
Sertraline Hcl	Sertraline Hcl	81	29
Eliquis	Apixaban	74	21
Fluticasone Propionate	Fluticasone Propionate	70	22
Potassium Chloride	Potassium Chloride	70	18
Famotidine	Famotidine	67	22
Metformin Hcl Er	Metformin Hcl	65	19
Albuterol Sulfate Hfa	Albuterol Sulfate	62	21
Carvedilol	Carvedilol	61	22
Simvastatin	Simvastatin	61	20
Ozempic	Semaglutide	58	suppressed
Trazodone Hcl	Trazodone Hcl	57	18
Furosemide	Furosemide	54	15
Tramadol Hcl	Tramadol Hcl	53	12
Montelukast Sodium	Montelukast Sodium	52	15
Escitalopram Oxalate	Escitalopram Oxalate	51	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	15
Prednisone	Prednisone	37	24
Allopurinol	Allopurinol	36	13
Spironolactone	Spironolactone	35	13
Venlafaxine Hcl Er	Venlafaxine Hcl	32	11
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Finasteride	Finasteride	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Torsemide	Torsemide	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Nystatin	Nystatin	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Atenolol	Atenolol	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Glipizide	Glipizide	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Linzess	Linaclotide	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Constulose	Lactulose	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ramipril	Ramipril	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error